LQDA - Liquidia Technologies Inc - SEC Form 4 Insider Trading Screener
Manufactured Goods - Specialty Instruments - Surgical & Medical Instruments & Apparatus - LQDA (1330436)
18 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019-12-27 | LQDA | Canaan VIII LP | 10% | P - Purchase | $3.13 | +319,488 | 2,917,169 | +12% | +$999,997 | ||||||
| D | 2019-08-22 | LQDA | Albury Timothy | SVP, Chief Accounting Officer | S - Sale+OE | $6.00 | -6,762 | 38,963 | -15% | -$40,572 | |||||
| DM | 2019-08-13 | LQDA | Albury Timothy | SVP, Chief Accounting Officer | S - Sale+OE | $6.87 | -1,386 | 37,526 | -4% | -$9,524 | |||||
| D | 2019-02-28 | LQDA | Maynor Benjamin | SVP, Research, Development | S - Sale+OE | $19.84 | -2,187 | 4,168 | -34% | -$43,388 | |||||
2019-02-22 | LQDA | Gordon Kevin K | Pres, CFO | S - Sale | $17.10 | -943 | 162,265 | -1% | -$16,130 | ||||||
2019-01-22 | LQDA | Gordon Kevin K | Pres, CFO | S - Sale | $14.66 | -11,322 | 163,208 | -6% | -$165,942 | ||||||
| M | 2018-11-13 | LQDA | Kirsch Arthur S | Dir | P - Purchase | $18.45 | +1,000 | 2,000 | +100% | +$18,448 | |||||
2018-11-08 | LQDA | Kirsch Arthur S | Dir | P - Purchase | $18.25 | +1,000 | 1,000 | New | +$18,250 | ||||||
| D | 2018-07-30 | LQDA | Sandell Scott D | 10% | P - Purchase | $11.00 | +545,455 | 2,484,870 | +28% | +$6,000,005 | |||||
| D | 2018-07-30 | LQDA | Kerins Patrick J | 10% | P - Purchase | $11.00 | +545,455 | 2,484,870 | +28% | +$6,000,005 | |||||
| D | 2018-07-30 | LQDA | Baskett Forest | 10% | P - Purchase | $11.00 | +545,455 | 2,484,870 | +28% | +$6,000,005 | |||||
| D | 2018-07-30 | LQDA | Barris Peter J | 10% | P - Purchase | $11.00 | +545,455 | 2,484,870 | +28% | +$6,000,005 | |||||
| D | 2018-07-30 | LQDA | Barrett M James | 10% | P - Purchase | $11.00 | +545,455 | 2,484,870 | +28% | +$6,000,005 | |||||
| D | 2018-07-30 | LQDA | Glaxosmithkline Plc | Former 10% holder | P - Purchase | $11.00 | +148,818 | 624,422 | +31% | +$1,636,998 | |||||
| D | 2018-07-30 | LQDA | Alexandria Venture Investments, LLC | 10% | P - Purchase | $11.00 | +136,364 | 396,172 | +52% | +$1,500,004 | |||||
| D | 2018-07-30 | LQDA | New Enterprise Associates 12, Limited Partnership | 10% | P - Purchase | $11.00 | +545,455 | 2,484,870 | +28% | +$6,000,005 | |||||
| D | 2018-07-30 | LQDA | Bloch Stephen M | Dir | P - Purchase | $11.00 | +727,273 | 2,563,303 | +40% | +$8,000,003 | |||||
| D | 2018-07-30 | LQDA | Canaan VIII LP | 10% | P - Purchase | $11.00 | +727,273 | 2,563,303 | +40% | +$8,000,003 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |